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Abstract
Background: Silencing of transgenes in mice is a common phenomenon typically associated with short multi-copy
transgenes. We have investigated the regulation of the highly inducible human granulocyte-macrophage colony-
stimulating-factor gene (Csf2) in transgenic mice.
Results: In the absence of any previous history of transcriptional activation, this transgene was expressed in T
lineage cells at the correct inducible level in all lines of mice tested. In contrast, the transgene was silenced in a
specific subset of lines in T cells that had encountered a previous episode of activation. Transgene silencing
appeared to be both transcription-dependent and mediated by epigenetic mechanisms. Silencing was
accompanied by loss of DNase I hypersensitive sites and inability to recruit RNA polymerase II upon stimulation.
This pattern of silencing was reflected by increased methylation and decreased acetylation of histone H3 K9 in the
transgene. We found that silenced lines were specifically associated with a single pair of tail-to-tail inverted
repeated copies of the transgene embedded within a multi-copy array.
Conclusions: Our study suggests that epigenetic transgene silencing can result from convergent transcription of
inverted repeats which can lead to silencing of an entire multi-copy transgene array. This mechanism may account
for a significant proportion of the reported cases of transgene inactivation in mice.
Background
The introduction of transgenes into the germline of ani-
mals and plants has become commonplace. Neverthe-
less, it remains difficult to routinely direct efficient and
persistent expression of small transgenes in transgenic
mice. One of the major problems facing transgenic
mouse model systems is that transgenes frequently
undergo silencing [1-3]. Transgene silencing is most
prevalent when genes integrate as multi-copy transgene
arrays [2,4,5] and it is normally accompanied by DNA
methylation and formation of a repressive chromatin
environment [1-3]. However, transgene silencing is not
restricted to small multicopy transgenes, because even
large single copy bacterial artificial chromosome (BAC)
transgenes are susceptible to silencing associated with
position effect variegation [6].
In mammalian transgenic models, it has been estab-
lished that transgene silencing is mediated by epigenetic
mechanisms but it is unclear why tandem arrays of
transgenes are so prone to silencing. There is evidence
that convergent transgenes are silenced more strongly
than tandem repeats, but it has also been observed that
any repeated arrangement of transgenes can undergo
some degree of silencing [7]. Although the mechanism
of transgene silencing in mammalian cells is not fully
understood, in plants there is also evidence that silen-
cing occurs predominantly at sites where transgene
arrays include inverted repeated DNA sequences
[4,8-12]. In such instances it has been suggested that
transgene silencing occurs via convergent transcription
and the synthesis of palindromic RNAs and RNAi. Until
recently, such a mechanism was not believed to exist in
mammalian cells. However, there is now substantial evi-
dence that targeting of siRNAs to active genes can
indeed direct epigenetic silencing in mammalian cells
via histone deacetylation and methylation [13-18].
We have created a transgenic mouse model that
allows us to study the induction of transgene silencing
within multi-copy transgene arrays in mammals. We
have generated lines of human granulocyte- macrophage
colony-stimulating-factor (GM-CSF) transgenic mice in
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which the GM-CSF gene (also called Csf2) is tightly
regulated and highly inducible [19,20]. We have demon-
strated that a 10.5 kb segment of the human GM-CSF
locus (Figure 1A) is sufficient to reproducibly support a
level of induction of GM-CSF expression per gene copy
that is indistinguishable from the endogenous mouse
GM-CSF locus [19,21]. In splenic T cells that have not
been previously activated, there is no evidence of silen-
cing of transgenes in any of the many GM-CSF trans-
genic lines we created, even though all of the lines
contain multiple copies (up to 90) of the locus [19,21].
However, in this study we show that after one episode
of transcription activation, the transgene is transcrip-
tionally silenced in a subset of lines associated with tail-
to-tail inverted repeats. Furthermore, we show that this
is an epigenetic phenomenon because the silenced trans-
genes contain the typical chromatin marks associated
with long-term silencing and lose the ability to recruit
RNA polymerase II. This suggests that convergent
transcription may represent a common fundamental epi-
genetic mechanism of gene silencing in transgenic mice.
Results
Correct regulation of GM-CSF transgenes in splenic T
lineage cells
Our group previously created transgenic mice from a
10.5 kb Xho I - Hind III segment of DNA carrying the
human GM-CSF gene and all of the elements required
for its correct regulation in vivo (Figure 1A) [19]. Trans-
gene expression was assayed in activated spleen cells
where the predominant GM-CSF-expressing cells are T
cells. We demonstrated that this transgene is expressed
in activated spleen cells in an inducible copy number-
dependent fashion at levels equivalent to the endogen-
ous mouse GM-CSF gene in 10 out of 11 independent
lines of transgenic mice.
Here we reanalysed GM-CSF transgene activity in a
variety of T lineage cell populations in seven of the
GM-CSF transgenic mouse lines (C183, A127, J253,
M268, G203, F201 and D184) carrying from two to 90
copies of the transgene (Figure 1). Freshly isolated
spleen cells were stimulated for 8 h with a combination
of the phorbol ester phorbol myristate acetate and the
calcium ionophore A23187 (PMA/I) to directly activate
T cell receptor signalling pathways. Human and mouse
GM-CSF expression levels were then measured by
ELISA. After correction for gene copy number, trans-
gene expression in all lines was efficiently induced to a
level approximately one to three times that of the endo-
genous mouse GM-CSF gene (Figure 1B). These data
confirm that the 10.5 kb transgene contains sufficient
information to correctly regulate GM-CSF gene expres-
sion in a position-independent and copy-number-depen-
dent manner.
Transcription-dependent silencing of GM-CSF transgenes
in previously activated T cells
In order to investigate transgene regulation in a defined
cell type we cultured actively dividing T cells derived
from the spleen. In order to induce proliferation, spleen
cells were activated in culture for 2 days in the presence
of the lectin Concanavalin A (ConA), which activates
receptor signalling pathways and induces cytokine gene
transcription. We confirmed that the GM-CSF gene
was, indeed, induced under these conditions (data not
shown). These rapidly dividing cells were further cul-
tured for several cell cycles in the presence of IL-2 and
in the absence of any cytokine gene-inducing agent for
an additional 2 days. This procedure reliably generates
cultures of ~98% pure T cells that have undergone blast
cell transformation from inactive non-dividing resting T
cells to rapidly proliferating T cells (T lymphoblasts).
Figure 1 Human granulocyte-macrophage colony-stimulating
factor (GM-CSF) transgene expression in T lineage cells. (A)
Map of the 10.5 kb Xho I-Hind III fragment of the human GM-CSF
locus used to make transgenic mice. (B and C) ELISAs of human
GM-CSF expression in cultures of transgenic splenocytes (B) and
previously activated T blast cells (C). The relative level of human
GM-CSF expression per gene copy is expressed as (human GM-CSF/
mouse GM-CSF)/(number of copies of human GM-CSF transgene/
two copies of mouse GM-CSF transgene). In each case cells were
stimulated for 15 h with 20 ng/ml PMA and 1 μM A23187. Error
bars indicate standard error. The number of copies of the transgene
is displayed below each line in panel C.
Calero-Nieto et al. Epigenetics & Chromatin 2010, 3:3
http://www.epigeneticsandchromatin.com/content/3/1/3
Page 2 of 13
After the 2 days of culture in IL-2, the T cells had
undergone at least five cell divisions since the cessation
of the initial episode of activation. Cells were then resti-
mulated with phorbol ester and calcium ionophore
(PMA/I). In lines A127, M268 and F201 the transgenes
were efficiently induced to levels roughly equivalent to
the endogenous mouse GM-CSF gene (Figure 1C). In
contrast, transgene activity was greatly reduced for lines
J253 and G203 and almost non-existent for lines C183
and D184. This indicated that a profound degree of
gene silencing had taken place subsequent to the initial
activation of the spleen cells. Note that splenocytes are
comprised primarily of quiescent cells that have had no
recent history of activation by agents that induce cyto-
kine gene transcription, whereas the cultured T cells
were recently activated and had transiently expressed
the transgenes. These observations suggest that a single
episode of transcriptional activation is, therefore, suffi-
cient to induce heritable transgene silencing in a specific
subset of lines that persists for at least several cell
cycles. The results are in marked contrast to our parallel
studies carried out on several lines that contain 130 kb
GM-CSF transgenes which do not undergo silencing in
T blast cells in any instances (Mirabella et al, in press).
This change in expression pattern is unlikely to be influ-
enced by any change in the proportions of CD4 and
CD8 positive T cells during culture because these two
populations show essentially identical levels of GM-CSF
expression (Mirabella et al, in press).
In summary, we have defined three transgenic lines
where regulation appears to be correct under all condi-
tions and four lines that are correctly regulated until
exposed to a cycle of transcriptional activation. In order
to further explore the basis of this post-activation-speci-
fic silencing we selected two correctly regulated lines
(A127 and M268) and two lines that are susceptible to
induction of silencing (J253 and D184) for further study.
In addition to having similar activities in spleen cells,
these four lines are also known to be expressed at
equivalent inducible levels in peritoneal myeloid cells
[21].
Transgene silencing occurs at the transcriptional level
The above findings were verified by real time polymer-
ase chain reaction (PCR) analysis of human and mouse
GM-CSF mRNA levels in T cells stimulated for 4 h with
PMA/I. As above, these cells had been first activated for
2 days in the presence of ConA and then cultured for
an additional 2 days after the removal of ConA. In lines
J253 and D184, human GM-CSF mRNA induction was
dramatically reduced compared to line A127, whereas
mouse GM-CSF mRNA was expressed at similar levels
in all lines (Figure 2A). This analysis also indicated that
the homologous mouse GM-CSF gene does not undergo
silencing in parallel with the human GM-CSF gene in
lines J253 and D184.
In order to confirm that these results reflect ongoing
transcription in the nucleus, and not just steady state
levels of cytoplasmic mRNA, we performed chromatin
immunoprecipitation (ChIP) assays to measure levels of
the Serine-2-phosphorylated elongating form of RNA
Figure 2 Transcriptional gene silencing in a subset of lines. (A)
Real time polymerase chain reaction (PCR) analyses of human and
mouse granulocyte-macrophage colony-stimulating factor (GM-CSF)
mRNA expression in transgenic T cells. GM-CSF expression in
spleen-derived T cells activated for 2 days in the presence of ConA,
and then cultured for 2 days in the absence of ConA and re-
stimulated for 4 h with 20 ng/ml phorbol myristate acetate (PMA)
and 2 μM A23187. Values are expressed relative to mouse
glyceraldehyde phosphate dehydrogenase (GAPDH) and divided by
transgene copy number. Error bars indicate standard deviation. (B)
chromatin immunopreciptation (ChIP) assay of the elongating Ser 2
phosphate form of RNA polymerase II performed on T lymphoblasts
prepared from mouse lines A127 (open boxes) and J253 (closed
boxes) before and after stimulation for 4 h with 20 ng/ml PMA and
1 μM A23187. This panel depicts a representative experiment but
we have obtained similar results in an independent analysis of lines
M268 and D184. (C) Time course of human GM-CSF induction in
spleen cells activated with 20 ng/ml PMA and 2 μM A23187.
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polymerase II within the coding region of the human
GM-CSF transgenes. Specific ChIP DNA levels were
measured before and after stimulation with PMA/I by
real time PCR using primer sets located within intron 2
of the GM-CSF gene. No recruitment of the elongating
form of RNA polymerase II could be detected in lines
D184 and J253, whereas a high level of inducible
recruitment was observed in lines A127 (Figure 2B) and
M268 (data not shown). This result confirms that silen-
cing takes place at the transcriptional level.
Next, we tried to determine whether transgene silen-
cing was a rapid process, becoming established coinci-
dent with the initial transcription initiation, or whether
it was a longer process that might even require DNA
replication. In order to study short term events we per-
formed a time course of stimulation of splenocytes with
PMA/I for up to 11 h (Figure 2C). Over this time per-
iod, human GM-CSF mRNA was induced with similar
kinetics in both lines A127 and D184 with no major
decrease in transgene activity in D184 at the later time
points. As GM-CSF mRNA is highly unstable, this sug-
gests that silencing takes more than 11 h to become
firmly established. Interestingly, this time course is con-
sistent with the reported kinetics of siRNA-mediated
epigenetic gene silencing [18].
Transgene silencing occurs at the level of chromatin
structure
The GM-CSF locus contains inducible DNase I hyper-
sensitive sites (DHSs) located at the promoter and
enhancer (Figure 3A) [19]. In order to explore epige-
netic mechanisms of transgene silencing, DHSs were
mapped in cultured T cells within the four chosen lines
of mice. In activated T cells from lines A127 and M268
the predicted DHSs formed within the transgenes (Fig-
ure 3B). However, the formation of these DHSs was
almost abolished in line J253 and completely abolished
in line D184. These changes in chromatin structure par-
alleled the expression data where the transgenes were
almost completely silenced in line D184 but incomple-
tely silenced in line J253 (Figures 1C and 2A).
In order to further explore the basis for this chroma-
tin-mediated gene silencing, we performed ChIP assays
to measure levels of acetylation and tri-methylation of
histone H3 K9 within the enhancer, promoter and cod-
ing region of the transgenes. These chromatin modifica-
tions have been widely associated with either active
(acetylation) or long-term silenced (tri-methylation)
regions. The ChIP assays indicated that the enhancer,
promoter and coding regions of the silenced J253 trans-
genes were each heavily modified by trimethylation of
histone H3 K9, whereas the active A127 transgenes
were not significantly modified (Figure 3C). For an inac-
tive control we also assayed a non-transcribed gene
Figure 3 Chromatin structure of granulocyte-macrophage
colony-stimulating factor (GM-CSF) transgenes. (A) Map of the
human GM-CSF transgene, showing the positions of the GM-CSF
gene and enhancer (E) and the locations of DNase hypersensitive
sites (DHSs). (B) Analysis of DHSs in T lymphoblasts stimulated for 8
h with 20 ng/ml phorbol myristate acetate (PMA) and 2 μM A23187.
Nil represents intact genomic DNA cleaved with Eco RI and the
right hand lane in each panel is an Eco RI digest of DNA derived
from DNase I-digested nuclei. The asterisks represent incomplete
copies of the transgene. Mapping was performed using a Sal I-Eco
RI fragment located within the GM-CSF gene. (C and D) Chromatin
immunoprecipitation assays (ChIP) of tri-methylation of histone H3
K9 (C) and acetylation of histone H3 K9 (D) with non-specific
immunoglobin G (IgG) as a ChIP antibody control. Assays were
performed on cultured T cells previously activated with ConA,
prepared from mouse lines A127 (open boxes) and J253 (closed
boxes) after stimulation for 4 h with 20 ng/ml PMA and 2 μM
A23187. Shown here are single representative experiments for lines
A127 and J253 that have been replicated using lines M268 and
D184, respectively.
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desert region of mouse chromosome 1 (mChrom1) and
found that this was equally methylated in both A127
and J253, although not as strongly as the silenced trans-
genes. ChIP assays also showed that silencing in J253
was accompanied by a decrease in acetylation of K9 in
all three regions of the transgenes in comparison with
A127 (Figure 3D). Additional ChIP assays were per-
formed on cultured T cells prepared from lines M268
and D184. These assays produced results with values
very similar to those shown in Figures 3C and 3D, with
D184 transgene silencing being accompanied by
decreased acetylation and increased tri-methylation of
H3 K9 relative to M268 (data not shown).
Transgene silencing is not mediated by DNA methylation
Changes in gene expression and histone modification
patterns are often, but not always, associated with
changes in DNA methylation. However, the GM-CSF
promoter region contains very few CG sequences that
might influence gene expression. Only one CG exists
within the -114 to +28 region that constitutes the
defined GM-CSF promoter and this is located within
the Sp1 site at -70 [22]. In order to investigate whether
DNA methylation is involved in the silencing of GM-
CSF transgenes we employed methylation-sensitive
restriction enzymes and direct DNA hybridisation analy-
sis of genomic DNA to determine the methylation status
of the Sp1 site in GM-CSF promoter. In order to mea-
sure any changes in the degree of methylation upon
silencing, DNA was purified for all four lines from both
spleen, which should not be silenced, and ConA-treated
cultured T cells (T blasts). Genomic DNA was digested
with Hae III in the presence and absence of the methy-
lation-sensitive enzyme Fau I which cleaves the CCCGC
sequence at the Sp1 site only if it is not methylated.
Hae III alone generates a 175 bp genomic DNA frag-
ment spanning the Sp1 site, whereas Fau I creates a 145
bp sub-fragment. Products were analysed by polyacryla-
mide gel electrophoresis and filter hybridisation (Figure
4A). Unexpectedly, all samples were equally highly resis-
tant to Fau I digestion of the Sp1 site. This suggested
that the Sp1 site was almost fully methylated in both
the spleen and the T blast cells, in both the active and
the repressed lines, and that there was no change in sta-
tus upon silencing. We confirmed that the low level of
Fau I cleavage was not due to under-digestion because a
parallel control analysis of a Fau I site located within a
non-methylated CG-island revealed complete cleavage
(Figure 4A). However, the significance of methylation of
the single CG that exists in the promoter is unclear
because DNA methylation does not necessarily interfere
with Sp1 binding or function [23]. DNA methylation
may not, in fact, play much of a role in the regulation of
GM-CSF expression because relatively few CG
sequences exist anywhere in the GM-CSF locus. Parallel
analyses of 4 Hpa II sites located from 153 to 2091 bp
downstream of the transcription start site suggested that
similar high levels of DNA methylation existed through-
out the GM-CSF gene in T cell DNA prepared from all
four transgenic lines and also in primary human T cells
(data not shown). Others have similarly shown that the
GM-CSF gene is comprised of methylated DNA in T
cells [24]. It is also now evident that it is common to
find that the bodies of active genes with low CG densi-
ties are in fact methylated [25].
Silenced transgenes are associated with inverted
convergent repeats
Silencing of GM-CSF transgenes appeared to be tran-
scription-dependent and one potential mechanism of
transgene silencing is convergent transcription. In multi-
copy transgenes this could lead to the formation of
palindromic RNA and siRNAs, which have the potential
to direct localised epigenetic silencing [13-16]. Although
transgenes typically integrate as head-to-tail copies
within multi-copy arrays, silencing could result from
convergent transcription of any less commonly
Figure 4 DNA methylation analysis . (A) Filter hybridization
analysis of Fau I cleavage of Hae III-digested genomic DNA
prepared from transgenic splenocytes and T lymphoblasts. Fau I
recognises the Sp1 site in the human granulocyte-macrophage
colony-stimulating factor (GM-CSF) promoter and is located within a
175 bp Hae III fragment which was used as the probe. DNA was
purified from either whole spleen or from cultured T cells previously
activated with ConA (T blasts). 5 μg of each DNA sample was
digested with either just Hae III, or Hae III plus Fau I. After
electrophoresis, DNA was electrophoretically transferred from a
polyacrylamide gel to a nylon membrane and hybridized with 32P-
labelled probes. (B) Reprobing of the same membrane used in (A)
with a DNA fragment encompassing a CG island within the mouse
adenine phosphoribosyltransferase gene.
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encountered tail-to-tail copies of transgenes. In order to
determine whether silenced lines do contain convergent
gene repeats, we performed a Southern blot hybridiza-
tion analysis of Afl II-digested DNA from each line,
using a probe at the 3’ end of the transgene to identify
restriction enzyme fragments diagnostic of convergent
inverted repeats. Afl II cuts once within the transgene
and will generate a 10.5 kb fragment from head-to-tail
repeats, a 6 kb band from tail-to-tail repeats and a band
of unknown size spanning the site where the 3’ end of
the transgene array has integrated into the mouse gen-
ome (Figure 5). Significantly, the diagnostic 6 kb
inverted repeat was present in both of the silenced lines
J253 and D184, and absent in A127 and M268 (Figure
5, left hand panel). Each lane also has at least one addi-
tional band that most probably represents the Afl II
fragment spanning the site of integration. In order to
exclude the possibility that the 6 kb Afl II bands repre-
sent either fragmented copies of the transgene or site of
integration products, we repeated this analysis with
three additional restriction enzymes and obtained simi-
lar findings, which suggests that the 6 kb Afl II bands
are, indeed, inverted repeats (data not shown). Densito-
metric quantitation of band intensities indicated that
each silenced line had just one pair of convergently
transcribed transgenes (data not shown).
In order to further confirm that the 6 kb Afl II pro-
ducts are true palindromes, we employed the tactic of
denaturing the digested DNA and rapidly renaturing the
single stranded products before loading the DNA on a
gel for Southern blot hybridisation analysis (Figure 5,
right-hand panel). Under these conditions, the hybridi-
zation kinetics do not favour the slow reannealing of
separate strands of homologous DNA but do favour the
rapid formation of hairpin structures from palindromes.
This analysis revealed the existence of the expected 3 kb
renatured hairpin product of the palindromic 6 kb Afl II
fragment only in the silenced lines J253 and D184.
Transgene junctions are transcribed
In order to determine whether there was the potential
for convergent transcription to generate palindromic
hairpin RNA species, we performed several analyses to
determine whether transcription occurred in the vicinity
of 3’ or 5’ junctions between individual copies of trans-
genes. Transgenic line C42 [21], which does not
undergo silencing, is derived from a 130 kb Age I DNA
fragment spanning the entire IL-3/GM-CSF locus and
including about 35 kb of DNA downstream of the GM-
CSF gene. In this line, it is unlikely that the GM-CSF
transgene could be subjected to anti-sense transcription
arising from adjacent copies. We therefore chose this
line as a more appropriate model to search for evidence
of sense strand transcription proceeding from the GM-
CSF gene and up to and beyond the 3’ Hind III site.
For the first RNA assay we performed Northern blot
hybridization analysis of total cellular RNA (T), nuclear
RNA (N) and cytoplasmic RNA (C) prepared from cul-
tured T cells from line C42 (Figure 6A). We detected
the predicted inducible 0.7 kb GM-CSF mRNA tran-
script in all three fractions of RNA (middle panel, Figure
6A). We also detected an inducible 3’ 2.7 kb nuclear
RNA species with a 1.0 kb probe encompassing a Bgl II
- Hind III fragment comprising the 3’ end of the trans-
gene (top panel, Figure 6A). Such a transcript could
potentially span the 3’ boundary of the transgene and
might be expected to exist as a palindrome at sites of
inverted repeats. This transcript could potentially repre-
sent a read-through transcript from the GM-CSF gene.
Figure 5 Analysis of inverted repeats in granulocyte-
macrophage colony-stimulating factor (GM-CSF) transgenic
mice. Southern blot hybridisation analysis of Afl II-digested DNA
purified from 4 lines of transgenic mice, as indicated. The left hand
panel is an analysis of double stranded DNA digested with Afl II and
probed with a 0.83 kb Afl II-Eco RI fragment of the GM-CSF gene.
The right hand panel is an analysis of the same samples after
denaturation at 99°C and rapid renaturation at 66°C before
electrophoresis. The schematic below illustrates potential products
and the probes employed to detect them. Sample preparation is
described in the methods section.
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We next performed strand-specific reverse transcrip-
tion of activated C42 T cell RNA, followed by PCR in
order to detect transcripts in two adjacent regions just
inside the 3’ Hind III site (amplicons A and B, Figure
6B). This revealed the presence of sense strand, but not
anti-sense strand transcripts, within 40 bp of the Hind
III site which probably proceed even further past this
point. If the same predicted pattern of transcription
occurs in lines J253 and D184, then this would, indeed,
generate palindromic hairpin RNA species that could
direct gene silencing.
We then examined lines A127, J253 and D184 for the
presence of this 3’ species of RNA. Curiously, in line
A127, in contrast to line C42, we were not able to
detect sense but did detect anti-sense strand transcripts
downstream of the GM-CSF gene with primer set B
(Figure 6C). These transcripts 3’ of the gene could
potentially arise from anti-sense transcripts originating
from the GM-CSF enhancer located within the next
downstream copy of the transgene. In support of this
view, our group has detected RNA polymerase II in
association with the GM-CSF enhancer in activated T
cells from transgenic line C42 in ChIP assays (Mirabella
et al, in press). We then examined line A127 in order to
determine whether there are anti-sense transcripts
potentially originating from the GM-CSF enhancer that
Figure 6 Analysis of non-coding RNA in granulocyte-macrophage colony-stimulating factor (GM-CSF) transgenic mice. (A) Northern blot
analysis of GM-CSF mRNA expression probed with 1.3 Sal I-Eco RI gene fragment, and 3’ non-coding RNA expression probed with a 1.0 kb Bgl
II-Hind III fragment. The lower panel shows methylene blue staining of RNA. (B and C) Strand-specific reverse transcription and PCR amplification
of regions A, B, C, and J using the primers listed in Table 2, and T cell RNA prepared before and after stimulation. Line C42 contains 6 copies of
a 130 kb segment of the GM-CSF locus whereas line A127 contains 4 copies of a 10.5 kb Xho I-Hind III fragment of the GM-CSF locus. PCR
reactions employed reverse transcriptase and PCR primers (PRT), primers but no reverse transcriptase (-RT), or reverse transcriptase without PCR
primers. Bars depict PCR amplicons. (D) Analysis of siRNAs in transgenic T cells. Either total RNA (lanes 1 to 4), or fractionated small RNA (lane 5)
was subjected to polyacrylamide gel electrophoresis, transferred to nylon membranes and hybridised with the probes described in the methods
section. RNA was prepared from cells either 1 (lanes 2 and 3), 3 (lane 3) or 7 (lanes 4 and 5) days after initial stimulation of spleen cells with
ConA, which was removed after the first 2 days. The upper panel encompasses the region of the filter where siRNAs should migrate (~20-25 bp).
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can traverse the 5’ boundary of the transgenes. This
could also generate palindromic RNA at inverted
repeats. We again used strand-specific reverse transcrip-
tion and PCR using primers either upstream (B) or
downstream (C) of the Xho I site that defines the 5’
boundary of each transgene copy (Figure 6C). Note that
probe B is, in fact, downstream of the GM-CSF gene
and is designed to detect transcription within adjacent
copies. We also employed primers that span the junc-
tion between transgenes (J). As before, in this analysis
we detected anti-sense, but not sense transcripts with
both the 5’ and the junction primer sets, and also with
additional primers closer to the enhancer (data not
shown). This suggests that the enhancer does, indeed,
direct transcription into neighbouring copies of the
transgene. We interpret these observations as an indica-
tion that 5’ anti-sense transcription from the enhancer
can suppress the competing 3’ sense strand transcription
from the gene in head-to-tail repeats of the transgene.
However, in the case of tail-to-tail repeats, there would
be no such suppression because there is no adjacent
downstream copy of the GM-CSF enhancer. These tran-
scripts were absent prior to the induction of the expres-
sion of the gene with PMA and calcium ionophore,
indicating that they are inducible (data not shown). We
have, however, been unable to detect any of these tran-
scripts in the silenced lines J253 and D184, very likely
due to the fact that GM-CSF transcription in these lines
is shut down after the act of epigenetic silencing (data
not shown).
Taken together, these data suggest that a single
inverted copy of a transgene, embedded within a tandem
array, does indeed have the potential to generate palin-
dromic RNAs at both boundaries of the transgene,
which could be the trigger for epigenetic silencing.
Small interfering (si) RNAs are not detected in silenced
transgenes
It has been well documented that double stranded RNAs
can lead to production of small RNAs after their proces-
sing. In order to search directly for the presence of GM-
CSF siRNAs in lines J253 and D184 we have performed
an extensive series of Northern blot analyses. One such
example is shown in Figure 6D. In this analysis we have
assayed either total cellular RNA, or a sample enriched
for low molecular weight RNA, from previously acti-
vated T cells prepared from lines A127, D184 and J253.
Although we can easily detect other specific small RNA
species, we were unable to detect any GM-CSF siRNAs
(Figure 6D). We have now completed many exhaustive
attempts at detecting a GM-CSF siRNA in the silenced
lines using various T cell preparations at different stages
of blast cell transformation, using a range of probes and
have failed to find such an RNA anywhere in the GM-
CSF locus (data not shown).
In mammalian cells, siRNAs are thought to be able to
direct epigenetic gene silencing by recruitment of Argo-
naute 1 or 2 [14,15]. However, we have also been unable
to detect any recruitment of either Argonaute 1 or 2 in
ChIP assays (data not shown). Hence, although it is
clear that GM-CSF transgene silencing is occurring at
the level of transcription, and is an epigenetic phenom-
enon, the precise mechanism of silencing remains
unknown.
Discussion
Multi-copy transgenic loci are not necessarily silenced
There is strong evidence that multi-copy transgenes are
prone to silencing, and at least one example in mamma-
lian cells where the removal of all but one copy of a
transgene is sufficient to relieve such silencing [2]. How-
ever, it remains unclear why transgene silencing has
only been observed in a proportion of the cases where
multi-copy transgene arrays have been studied. In
apparent contrast to some previous studies, we did not
observe silencing of tandemly repeated head-to-tail
transgenes and we found that a 90 copy transgene array
was expressed just as efficiently per gene copy as a four
copy transgene array (Figure 1) [19]. It is generally
assumed that transgenes integrate in transgenic mice as
direct repeats and, for the most part, they do. However,
we have shown that transgenes can also integrate into
arrays at low frequency as inverted repeats. Significantly,
we have shown that transcriptional silencing takes place
in the subset of lines that contains inverted repeats of
convergent transgenes, which suggests that these facts
may be directly related. There is at least one other
known example of a transgenic mouse line where trans-
genes have integrated as inverted repeats and are
expressed at an unexpectedly low efficiency [26]. We
also suggest that the mere act of convergent transcrip-
tion is unlikely to be sufficient since we have clearly
demonstrated that the GM-CSF locus generates both 3’
sense and 5’ anti-sense transcripts and so there must
logically be a point in our head-to-tail multi-copy trans-
genic lines where these opposing transcripts converge
without this process leading to silencing of these loci.
While we have presented one possible explanation for
multi-copy transgene silencing, this is not the only
mechanism by which multi-copy transgenes can be
silenced. For example, in Drosophila there is evidence of
pairing of homologous sequences such that even head-
to-tail repetitions of transgenes can lead to heterochro-
matin formation and transgene silencing [27]. However,
this is in contrast to what we have observed in mouse T
cells.
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Transgene silencing is an epigenetic phenomenon
We have also shown that maintenance of GM-CSF
transgene silencing in T cells is accompanied by the for-
mation of a repressive chromatin environment that
resembles heterochromatin. As suggested by our ChIP
assays, the formation of this repressive chromatin envir-
onment is most probably driven by modifications that
include deacetylation of histones followed by trimethyla-
tion of histone H3 K9. Heritable silencing of the trans-
genes in lines J253 and D184 was accompanied by the
absence of DHSs. This suggests that not just the
inverted copies of the locus, but the entire transgene
array of 10 or 11 copies, was converted to condensed
inactive chromatin. This effect is specific for the trans-
genes since the expression of the endogenous copy of
the mouse GM-CSF gene was not affected. Others have
reported that transgene silencing associated with posi-
tion effect variegation is also accompanied by a loss of
DHSs within regulatory elements [6]. As we have not
examined expression at the single-cell level, we are
unable to state whether GM-CSF transgene silencing
involves reduced expression in all cells or position effect
variegation.
DNA methylation does not appear to be important in
the silencing process because the GM-CSF promoter
and transcription unit were highly methylated even in
the fully active transgenes and the level of methylation
did not change after silencing. Similarly, it has been
reported by others that gene silencing is not always
associated with changes in DNA methylation [28].
Furthermore, there is evidence from a chicken cell
model system that, during the process of transgene
silencing, transgene transcriptional inactivation and his-
tone hypoacetylation precede the onset of DNA methy-
lation [29]. Furthermore, even active genes can be
targeted for DNA methylation [25].
Convergent transcription is followed by transcriptional
silencing
This study has established that inducible GM-CSF trans-
gene silencing occurs at the transcriptional level and
strongly suggests that it is a transcription-dependent
process. This may be a more common phenomenon
than is currently appreciated because it is not very com-
mon for investigators to examine the orientation of the
transgenes in studies such as this. Furthermore, many of
the transgenes that have been investigated are constitu-
tively active and preclude any analysis of inducible tran-
scription-dependent silencing. In one study of the
constitutively active a-globin enhancer transgene in ery-
throid cells it was found that a greater than 100 copy
array was silenced but a single copy transgene in the
same locus was not [2]. However, in this instance it is
not known if silencing was accompanied by the presence
of inverted repeats, and the timing of silencing could
not be examined. In another study, this issue was exam-
ined more directly by inserting pairs of transgenes in
various orientations and it was found that the conver-
gent arrangement led to the most pronounced silencing
of the transgenes [7]. However, in this study, any
arrangement of two transgenes was more susceptible to
silencing than a single transgene and silencing occurred
despite the presence of the SV40 polyadenylation/tran-
scription termination elements downstream of the trans-
genes. Hence, silencing of convergent transcription units
does not necessarily always involve an overlap of the
actual transcripts.
The generation of long regulatory RNA transcripts by
enhancers and locus control regions (LCRs) has been
extensively reported [30-32]. If transgene silencing is
transcription-dependent, then the nature of the promo-
ter and enhancer elements in transgenes may also have
a large bearing on whether or not a transgene becomes
silenced. Hence, the positioning of enhancers or LCRs
upstream or downstream of transgenes, close to trans-
gene boundaries, may also increase the likelihood of
silencing at inverted repeats [30-32]. Furthermore, there
is direct evidence that inclusion of the b-globin LCR in
transgenes can, in fact, lead to transgene silencing via a
mechanism that it is likely to involve transcriptional
interference [33]. Similar to our findings, establishment
of silencing in this model system was a slow process,
and, once silenced, the transgenes retained a stable epi-
genetic imprint that maintained silencing [34]. In this
instance, gene silencing was dependent upon the orien-
tation of the transgene, but not the LCR, and it was
apparent that silencing was triggered by activation of
transcription within non-coding flanking sequences
[33,34]. Hence, this could also involve an siRNA-depen-
dent mechanism, whereby the LCR induces transcripts
within flanking sequences in the opposite orientation to
convergent transcripts directed by the transgene promo-
ter [33]. Such a mechanism could, in principle, be an
alternative explanation for our findings. Furthermore,
via this mechanism, even single copy transgenes are
prone to silencing, depending upon the site and orienta-
tion of integration.
As mentioned above, it has already been established
that transgene silencing in plants can occur via conver-
gent transcription and the synthesis of palindromic
RNAs and RNAi. Furthermore, it is possible to relieve
silencing at palindromic sequences in plants by deleting
one copy of the inverted repeated sequence [8]. On the
other hand, non-coding RNA-mediated silencing is
reported to be able to occur independently of the RNAi
pathway [35,36]. The fact that we have failed to detect
any small RNAs derived from the silenced transgenes
precludes us from making any statements one way or
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the other as to whether GM-CSF transgene silencing
involves siRNA. However, we suggest that the formation
of palindromic RNAs may be central to the silencing
process. Furthermore, several studies have led to the
model whereby siRNA may pair with nascent transcripts
at gene loci in order to direct epigenetic silencing via
Argonaute family protein-dependent processes thought
to direct recruitment on the histone methyl transferase
Suv39H1 and HDAC-1 [13-15,17,18]. This would be
consistent with our evidence of reduced acetylation and
increased methylation of histone H3 K9 within silenced
transgenes. Our findings are also consistent with obser-
vations that siRNA-mediated epigenetic silencing
requires up to 3 days to induce and is stable for over a
month [18].
The role of non-coding transcripts in the GM-CSF
locus is not clear, but misdirected transcripts may well
have unwanted consequences. The human genome is
widely transcribed, but only a small proportion of the
transcribed RNAs codes for a protein product [37].
Although the existence of non-coding RNAs (ncRNAs)
is very well known [38], in general their functions are
not well understood yet. Over the last few years, the
function of the ncRNAs has been subjected to exhaus-
tive studies and its important regulatory role has
become evident [39]. They have been linked to many
processes such as the silencing of imprinted genes
[40-42] and gene regulation [43]. In transgenes, there is
plenty of potential for these ncRNAs to have suppressive
effects, and so the precise organisation of transgenic loci
is all important.
Conclusions
Our study provides new insights regarding the stability of
gene expression in transgenic assays. We have clearly
shown that transgene silencing does not correlate with
copy number, but, more importantly, it seems to corre-
late with the configuration of the transgene. Our results
show that silencing is heritable through several cell cycles
and occurs at the level of chromatin. We provide data
demonstrating that either read-through or other non-
coding sense-strand transcripts can be detected down-
stream of the GM-CSF gene. Potentially, these transcripts
could form palindromes in tail-to-tail configurations and
may, thus, cause silencing of the associated transgenic
gene locus. This mechanism, involving either read-
through transcription or enhancer-derived transcription,
could be responsible for a significant proportion of the
many other cases where silencing of transgenes has been
reported. This phenomenon may also be restricted to
short transgenes lacking significant 3’ flanking sequences
able to buffer the coding regions, as we see no such silen-
cing with 130 kb BAC transgenes and there is some
acceptance that large BACs are, in general, less prone to
silencing in transgenic mice. These findings point to the
possibility of including efficient transcription terminators
downstream of the transcribed regions of transgenes as a
means of lessening the incidence of transgene silencing.
Although there is some evidence that this approach will
not always work [7], others have found that inclusion of
an efficient polyadenylation and transcription pause site




The transgenic mouse lines A127, M268, J253, D184,
C183, G203 and F201 are all previously described lines
created from a 10.5 kb Xho I-Hind III segment of the
human GM CSF gene [19]. Note that line J253 was pre-
viously referred to as J10 in the original publication
[19,21] and that, since the original characterization of
these mice, the transgene copy number in each line has
been recalculated by Southern blot hybridization analy-
sis in a more recent publication [19,21]. The revised
copy numbers are displayed in Figure 1C.
All of the studies involving animals followed interna-
tionally recognized guidelines and were peer-reviewed
and approved by the appropriate local institution and
national ethical review bodies. All studies performed at
the University of Leeds were approved by the University
of Leeds Ethical Review Committee and were also
reviewed and granted a Project Licence by the UK
Home Office (approvals PPL 40/2471 and PPL 40/3086).
Previous published studies that generated mice used
here were approved by the Institute of Medical and
Veterinary Science Animal Ethics Committee in Ade-
laide, Australia (approval 5/97).
Cells
Single cell suspensions of splenocytes were prepared by
gently crushing spleens and extracting the free cells with
culture medium, as previously described [19]. Previously
activated proliferating T cells were prepared from
spleens by stimulation for 2 days with 2 μg/ml concana-
valin A (ConA) in order to induce proliferation, fol-
lowed by 2 days of culture in the absence of ConA and
in the presence of 10 U/ml mouse IL-2, as previously
described [19]. When re-stimulated, these cultured T
cells were incubated for 4 h, in the presence of 20 ng/
ml phorbol 12-myristate 13-acetate (PMA) and 2 μM
calcium ionophore A23187 (I), in order to activate T
cell receptor signalling pathways that normally induce
GM-CSF expression.
GM-CSF ELISAs
Human and mouse GM-CSF protein levels in cell cul-
ture media were measured by ELISA (R & D Systems,
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Oxfordshire, UK) after 15 h of stimulation with 20 ng/
ml PMA and 1 μM A23187. The relative activity per
gene copy was calculated as the ratio of (human GM-
CSF/mouse GM-CSF)/(transgene copy number/2).
Real time PCR analyses of gene expression
Total cellular RNA was isolated using Trizol (Invitrogen,
Renfrew, UK) according to the manufacturer’s instruc-
tions. Human and mouse GM-CSF and mouse glyceral-
dehydes phosphate dehydrogenise (GAPDH) mRNA
levels were measured by real time PCR analysis of
cDNA primed using olio (dot), as previously described
[20], using the primer sets listed in Table 1.
Strand-specific PCR analysis of ncRNAs expression
Strand specific reverse transcription and PCR was per-
formed using the primers listed in Table 2 for regions
located approximately 0.5 kb 5’ (A) or 0.1 kb 5’ (B) of
the Hind III site defining the 3’ end of the transgene,
0.1 kb 3’ of the Xho I site that defines the 5’ end of the
transgene (C) or were designed to span the Hind III/
Xho I junction between head-to-tail copies of transgenes
(J).
CDNA was synthesised with Thermo-X Reverse Tran-
scriptase from Invitrogen (Renfrew, UK). All RNA sam-
ples were pre-treated with DNase I to remove
contaminating traces of genomic DNA. Each cDNA
reaction contained 500 ng RNA and 2 μM specific oli-
gonucleotide primers in 20 μl. In order to increase the
strand specificity, we attached a linker sequence (Table
2) to the 5’ end of each specific primer. Three reactions
per cDNA synthesis were set up: one with reverse tran-
scriptase and with specific primer; one with reverse
transcriptase but without primer (to control for poten-
tial endogenous priming); and one without reverse tran-
scriptase but with primer (to control for potential DNA
contamination) (designated as PRT, -P and -RT, respec-
tively, in Figure 6B). After the RNA denaturation step at
65°C, tubes were kept at 60°C throughout the procedure
in order to prevent endogenous random priming. For
cDNA synthesis, reactions were incubated at 60°C for
30 min with 1 μl of Thermo-X Reverse transcriptase.
The reverse transcriptase was then inactivated by incu-
bating at 90°C for 5 min. The primers used with reverse
transcriptase are listed in Table 2 and are designated as
‘s RT’ or ‘as RT’ depending on whether they were
designed to detect sense or anti-sense transcripts,
respectively.
Subsequent to the reverse transcription step, to
amplify cDNA PCRs were performed with Invitrogen
native Taq DNA polymerase (Invitrogen, Renfrew, UK).
Five per cent of the specific cDNA synthesis product
obtained above was used as a template in each reaction.
PCR was performed using one cycle at 95°C for 3 min,
31 cycles of 95°C 30 s, 60°C 30 s, 72°C 1 min 30 s and
one cycle of 72°C for 5 min. For each PCR reaction, one
primer containing the linker sequence was used in place
of the RT primers used above, together with specific
reverse direction primers (denoted as Rev) as listed in
Table 2.
Table 1 Real time polymerase chain reaction (PCR)
primers.
Real time PCR primers
h GM-CSF mRNA CACTGCTGCTGAGATGAATGAAA
GTCTGTAGGCAGGTCGGCTC
m GM-CSF mRNA ATGCCTGTCACGTTGAATGAAG
GCGGGTCTGCACACATGTTA
m GAPDH mRNA TGGTGAAGCAGGCATCTGAG
TGTTGAAGTCGCAGGAGACAAC
ChIP primers
h GM-CSF enhancer GGAGCCCCTGAGTCAGCAT
CATGACACAGGCAGGCATTC
h GM-CSF promoter TGTCGGTTCTTGGAAAGGTTCA
TGTGGAATCTCCTGGCCCTTA
h GM-CSF intron 2 (+ 469 to 533 bp) ATGGCAGTCACATGAGCTCCTT
TGAAGTGACCCCCACTTTACCA
m CD2 promoter CTCTCTCCTTCCCCATCTCTACCT
CAACCTGAACCACGTGTCTTTC
m chromosome 1 (mChrom1) CATAGATGAAGCTGCCACATAGGT
GTGGGCAAGGACAAAGCATTA
GM-CSF, granulocyte-macrophage colony-stimulating factor; GAPDH,
glyceraldehyde phosphate dehydrogenase
Table 2 Non-coding RNA strand-specific reverse
transcription and polymerase chain reaction primers.
Linker CGACTGGAGCACGAGGACAC
A as RT CGACTGGAGCACGAGGACACCAGAGCCCTGAACCTGTTTC
A as R ATGTAAACCTTCGTTATGTGATG
A s RT CGACTGGAGCACGAGGACACATGTAAACCTTCGTTATGTGATG
A s Rev CAGAGCCCTGAACCTGTTTC




B s RT CGACTGGAGCACGAGGACACCCTGAGAATCTCTGAATCCCCA
B s Rev CACAGGTGGCTATCCTCTGGAA








C s RT CGACTGGAGCACGAGGACACTGACAGCCTCCCAGCCTTCTCA
C s Rev GGGGTGGGGAGGCTTTAG
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ChIP assays
ChIP assays were performed essentially as published in
reference [21]. Upstate antibodies: 5 μg anti-acetyl his-
tone H3 K9 (07-352), 2 μg anti-tri-methyl histone H3
K9, 5 μg of rabbit polyclonal IgG (12-370). Abcam anti-
body: 2 μg of anti-RNA polymerase II Ser-2 phosphate
(ab5095-100). Real time PCR was used to determine the
amount of each gene-specific amplicon present. All
values were determined from standard curves using
input DNA purified from sonicated chromatin. ChIP
data was normalised by expressing the amount of each
specific DNA precipitated as a ratio with the values
obtained with either an inactive region of mouse chro-
mosome 1 (mChrom1) or the promoter region of the
expressed CD2 gene. Primer sequences are shown in
Table 1.
Analysis of DNase I hypersensitive sites
DNase I hypersensitive sites (DHSs) were mapped
within T cell nuclei as previously described [20,45] from
a Eco RI site at the 3’ end of human GM-CSF gene,
using a 1.2 kb Sal I-Eco RI fragment of the gene as a
probe to detect DHSs in the GM-CSF gene promoter
and enhancer.
DNA methylation analysis
Genomic DNA was digested with Hae III in the pre-
sence and absence of Fau I, separated by polyacrylamide
gel electrophoresis, electrophoretically transferred to a
Hybond N nylon membrane and hybridized with 32P-
labelled DNA probes. Probe DNA templates were pre-
pared by PCR and were designed to recognise either the
175 bp Hae III fragment within the human GM-CSF
promoter or the 153 bp Hae III fragment of a CG island
located within the mouse adenine phosphoribosyltrans-
ferase gene.
Detection of palindromes
In order to detect inverted repeat sequences, 5 μg of
DNA purified from each transgenic line was digested
with Afl II and analysed by Southern blot hybridisation
analysis using a 0.83 kb Afl II-Eco RI fragment of the
GM-CSF gene as a probe.
In order to create and detect hairpin structures from
DNA fragments containing inverted repeats, DNA
digested with Afl II was heated at 99°C for 10 min, gra-
dually cooled over ~15 min to 66°C, incubated at 66°C
for 15 min, cooled to room temperature and then ana-
lysed by Southern blot hybridisation as above.
Detection of small RNAs
Total RNA was purified from cells as above for the gene
expression analyses. Small RNAs were prepared from
total RNA by precipitation of large RNAs with 5%
polyethylene glycol 8000 and 0.5 M NaCl, followed by
addition of 0.1 volume of 3 M Na Acetate, pH 5.5 and
precipitation of small RNAs with 3 volumes of ethanol.
RNA was analysed by electrophoresis on 15% polyacry-
lamide gels containing 7 M urea, followed by electro-
phoretic transfer to Hybond N+ membranes and
fixation using 0.12 J/cm2 ultraviolet light. Membranes
were sequentially hybridised with either a 3.2 kb Hind
III-Eco RI fragment encompassing the entire GM-CSF
gene and promoter, or previously published DNA oligo-
nucleotide probes complementary to either mouse U6
small nuclear RNA (snU6) (TGTGCTGCCGAAGC-
GAGCAC) or mouse micro RNA 142 (miR-142)
(CTAGTGCTTTCTACTTTATG) [46]. Hybridizations
were performed for 2 hours in RapidHyb buffer (Amer-
sham) at 50°C, and membrane washes were performed
in 300 mM NaCl, 30 mM Na citrate, 1 mM Na pyro-
phosphate, 0.2% Na dodecyl sulphate, pH 7 for 30 min
at 50°C.
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